This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jacquemont, C. Articles by Taniguchi, T. Search for Related Content PubMed PubMed Citation Articles by Jacquemont, C. Articles by Taniguchi, T.

Proteasome Function Is Required for DNA Damage Response and Fanconi Anemia Pathway Activation

Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington

Requests for reprints: Toshiyasu Taniguchi, Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, C1-015, Seattle, WA 98109-1024. Phone: 206-667-7283; Fax: 206-667-5815; E-mail: ttaniguc{at}fhcrc.org.

Proteasome inhibitors sensitize tumor cells to DNA-damaging agents, including ionizing radiation (IR), and DNA cross-linking agents (melphalan and cisplatin) through unknown mechanisms. The Fanconi anemia pathway is a DNA damage–activated signaling pathway, which regulates cellular resistance to DNA cross-linking agents. Monoubiquitination and nuclear foci formation of FANCD2 are critical steps of the Fanconi anemia pathway. Here, we show that proteasome function is required for the activation of the Fanconi anemia pathway and for DNA damage signaling. Proteasome inhibitors (bortezomib and MG132) and depletion of 19S and 20S proteasome subunits (PSMD4, PSMD14, and PSMB3) inhibited monoubiquitination and/or nuclear foci formation of FANCD2, whereas depletion of DSS1/SHFM1, a subunit of the 19S proteasome that also directly binds to BRCA2, did not inhibit FANCD2 monoubiquitination or foci formation. On the other hand, DNA damage–signaling processes, such as IR-induced foci formation of phosphorylated ATM (phospho-ATM), 53BP1, NBS1, BRCA1, FANCD2, and RAD51, were delayed in the presence of proteasome inhibitors, whereas ATM autophosphorylation and nuclear foci formation of H2AX, MDC1, and RPA were not inhibited. Furthermore, persistence of DNA damage and abrogation of the IR-induced G₁-S checkpoint resulted from proteasome inhibition. In summary, we showed that the proteasome function is required for monoubiquitination of FANCD2, foci formation of 53BP1, phospho-ATM, NBS1, BRCA1, FANCD2, and RAD51. The dependence of specific DNA damage–signaling steps on the proteasome may explain the sensitization of tumor cells to DNA-damaging chemotherapeutic agents by proteasome inhibitors. [Cancer Res 2007;67(15):7395–405]

This article has been cited by other articles:

				R. J. Katzenberger, M. S. Marengo, and D. A. Wassarman Control of Alternative Splicing by Signal-dependent Degradation of Splicing-regulatory Proteins J. Biol. Chem., April 17, 2009; 284(16): 10737 - 10746. [Abstract] [Full Text] [PDF]

				K. Watanabe, K. Iwabuchi, J. Sun, Y. Tsuji, T. Tani, K. Tokunaga, T. Date, M. Hashimoto, M. Yamaizumi, and S. Tateishi RAD18 promotes DNA double-strand break repair during G1 phase through chromatin retention of 53BP1 Nucleic Acids Res., April 1, 2009; 37(7): 2176 - 2193. [Abstract] [Full Text] [PDF]

				G. Shao, D. R. Lilli, J. Patterson-Fortin, K. A. Coleman, D. E. Morrissey, and R. A. Greenberg The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaks PNAS, March 3, 2009; 106(9): 3166 - 3171. [Abstract] [Full Text] [PDF]

				W. Shi, Z. Ma, H. Willers, K. Akhtar, S. P. Scott, J. Zhang, S. Powell, and J. Zhang Disassembly of MDC1 Foci Is Controlled by Ubiquitin-Proteasome-dependent Degradation J. Biol. Chem., November 14, 2008; 283(46): 31608 - 31616. [Abstract] [Full Text] [PDF]

				R. Sakasai and R. Tibbetts RNF8-dependent and RNF8-independent Regulation of 53BP1 in Response to DNA Damage J. Biol. Chem., May 16, 2008; 283(20): 13549 - 13555. [Abstract] [Full Text] [PDF]